The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer
Due to the therapeutic resistance of endocrine therapy and the limited efficacy of immune checkpoint inhibitors in estrogen receptor (ER)-positive breast cancer (BRCA), there is an urgent need to develop novel prognostic markers and understand the regulation of the tumor immune microenvironment (TIM...
Main Authors: | Cheng Zhang, Zhihua Li, Kaiheng Hu, Yifei Ren, Haoran Zhang, Yuankang Zhao, Wenjing Wei, Shuo Tu, Xiaohua Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1308807/full |
Similar Items
-
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
by: Zhenghui Cheng, et al.
Published: (2021-04-01) -
Sox4 Up-Regulates Cyr61 Expression in Colon Cancer Cells
by: Gang Wu, et al.
Published: (2014-07-01) -
Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
by: Xiaoting Huang, et al.
Published: (2018-05-01) -
CYR61—An angiogenic biomarker to early predict the impaired healing in diaphyseal tibial fractures
by: Sabir Ali, et al.
Published: (2017-07-01) -
Expression of Cyr61 is associated with clinical course in patients with Crohn’s disease
by: Su-Mi Lee, et al.
Published: (2021-03-01)